Genomic Health has made a number of changes to its management team and board of directors (see story, this issue).
The company has hired Sam Levy as chief scientific officer, replacing Joffre Baker, who will now serve as senior biology fellow at Genomic Health.
Levy is the director of genomic sciences at Scripps Translational Science Institute and Scripps Genomic Medicine, as well as a professor of molecular and experimental medicine at the Scripps Research Institute.
Previously, Levy served as director and professor in human genomics at the J. Craig Venter Institute, where he was the leading scientist on the first published diploid genome sequence of a human. He holds a BS in molecular biophysics from the University of Leeds and a PhD in cell and computational biology from the University of Bristol.
Randy Scott has stepped down from Genomic Health's board of directors to take on the position of CEO at InVitae, a Genomic Health spinout that will focus on integrating next-generation sequence data into medical practice for patients with rare and common genetic diseases.
Scott was a founder and former CEO of Genomic Health. Prior to founding the company, he served as president and chief scientific officer at Incyte Pharmaceuticals and director of protein biochemistry and senior director of research at Invitron.
He holds a PhD in biochemistry from the University of Kansas and a BS in chemistry from Emporia State University.